Biotherapeutics Translational Research Center (바이오신약중개연구센터)
Results 1-20 of 93 (Search time: 0.002 seconds).
No. | Year | Title | Type |
---|---|---|---|
93 | 2025 | 2025Article Gemcitabine resistance by CITED4 upregulation via the regulation of BIRC2 expression in pancreatic cancerJournal of Biomedical Science, vol. 32, pp. 49-49Eun Jeong Jeong; YuNa Roh; Eunsun Jung; Jin-Seong Hwang; Taesang Son; Hyun Seung Ban; Jang Seong Kim; Y K Choo; Tae-Su Han |
Article |
92 | 2025 | 2025Article Fusogenic nanoreactor-based detection of extracellular vesicle-derived miRNAs for diagnosing atherosclerosisSmall, vol. 21, no. 23, pp. 2501789-2501789Jiyoon Lee; Kiyoon Kwon; Min Ji Cho; Taesang Son; Yuna Roh; Sugi Lee; Dae Soo Kim; Moo-Seung Lee; Hyun Seung Ban; Jang Seong Kim, et al. |
Article |
91 | 2025 | 2025Research Project 막수용체 유전자군 조절을 통한 난치암 동반진단 항암제 개발 = Development of Targeted Cancer Drugs with Companion Diagnostics based on Regulation of G-protein Coupled Receptor Targetome연구책임자 : 반현승 / 사업기간 : 2025.01.01 ~ 2025.12.31 |
Research Project |
90 | 2025 | 2025Research Project 폐암 저산소 미세환경 조절 기반 GPCR 표적 대사항암제 연구 = Hypoxia-associated GPCRs regulating lung cancer metabolism연구책임자 : 반현승 / 사업기간 : 2025.03.01 ~ 2026.02.28 |
Research Project |
89 | 2024 | 2024Patent SYT11 억제제를 유효성분으로 포함하는 위암 치료용 조성물CN201980068374.8 (2021.04.16) / ZL201980068374.8 (2024.08.20)원미선; 김보경; 반현승; 박경찬; 염영일 |
Patent |
88 | 2024 | 2024Research Project 막수용체 유전자군 조절을 통한 난치암 동반진단 항암제 개발 = Development of Targeted Cancer Drugs with Companion Diagnostics based on Regulation of G-protein Coupled Receptor Targetome연구책임자 : 반현승 / 사업기간 : 2024.01.01 ~ 2024.12.31 |
Research Project |
87 | 2024 | 2024Research Project 재발성 및 불응성 다발성골수종 치료를 위한 19S RP UCHL5 저해 화합물 개발 = Development of 19S RP UCHL5 inhibitors for the treatment of relapsed and refractory multiple myeloma연구책임자 : 반현승 / 사업기간 : 2024.01.01 ~ 2024.07.31 |
Research Project |
86 | 2024 | 2024Article Stilbenoid derivatives as potent inhibitors of HIF-1α-centric cancer metabolism under hypoxiaBiomedicine & Pharmacotherapy, vol. 176, pp. 116838-116838Tae Hee Han; J Lee; D S Harmalkar; H Kang; G Jin; M K Park; M Kim; Hyun A Yang; Jinsu Kim; S J Kwon, et al. |
Article |
85 | 2024 | 2024Research Project 폐암 저산소 미세환경 조절 기반 GPCR 표적 대사항암제 연구 = Hypoxia-associated GPCRs regulating lung cancer metabolism연구책임자 : 반현승 / 사업기간 : 2024.03.01 ~ 2025.02.28 |
Research Project |
84 | 2024 | 2024Article CYB5R3 functions as a tumor suppressor by inducing ER stress-mediated apoptosis in lung cancer cells via the PERK-ATF4 and IRE1α-JNK pathwaysExperimental and Molecular Medicine, vol. 56, no. 1, pp. 235-249Joo-Young Im; S J Kim; Jong Lyul Park; Tae Hee Han; Woo-Il Kim; Inhyub Kim; Bomin Ko; So-Young Chun; Mi-Jung Kang; Bo Kyung Kim, et al. |
Article |
83 | 2024 | 2024Research Project 특정이자 활용사업(바이오의약연구부) = 특정이자 활용(바이오의약연구부)연구책임자 : 지승욱 / 사업기간 : 2024.03.18 ~ 2024.12.31 |
Research Project |
82 | 2023 | 2023Patent UCH37 탐지용 프로브 및 이의 용도KR10-2021-0142123 (2021.10.22) / 10-2576102-0000 (2023.09.04)반현승; 원미선; 한태수; 한태희 |
Patent |
81 | 2023 | 2023Patent DDIAS 억제제 및 사멸 수용체 리간드를 포함하는 암의 예방 또는 치료용 조성물KR10-2017-0115249 (2017.09.08) / 10-2532779 (2023.05.10)원미선; 임주영; 김보경; 반현승 |
Patent |
80 | 2023 | 2023Research Project 폐암 저산소 미세환경 조절 기반 GPCR 표적 대사항암제 연구 = Hypoxia-associated GPCRs regulating lung cancer metabolism연구책임자 : 반현승 / 사업기간 : 2023.03.01 ~ 2024.02.29 |
Research Project |
79 | 2023 | 2023Article The EDN1/EDNRA/β-arrestin axis promotes colorectal cancer progression by regulating STAT3 phosphorylationInternational Journal of Oncology, vol. 62, pp. 13-13Yeo Jin Lee; Eunsun Jung; Jinhyeon Choi; Jinseong Hwang; Eun-Jeong Jeong; Yuna Roh; Hyun Seung Ban; Sunhong Kim; Seon-Kyu Kim; Seon-Young Kim, et al. |
Article |
78 | 2023 | 2023Article Hemicyanine-based near-infrared fluorescence off-on probes for imaging intracellular and in vivo nitroreductase activityInternational Journal of Molecular Sciences, vol. 24, no. 7, pp. 6074-6074Sun Hyeok Lee; Chul Soon Park; Kyung Kwan Lee; Tae Hee Han; Hyun Seung Ban; Chang-Soo Lee |
Article |
77 | 2023 | 2023Research Project 재발성 및 불응성 다발성골수종 치료를 위한 19S RP UCHL5 저해 화합물 개발 = Development of 19S RP UCHL5 inhibitors for the treatment of relapsed and refractory multiple myeloma연구책임자 : 반현승 / 사업기간 : 2023.01.01 ~ 2023.12.31 |
Research Project |
76 | 2023 | 2023Research Project 막수용체 유전자군 조절을 통한 난치암 동반진단 항암제 개발 = Development of Targeted Cancer Drugs with Companion Diagnostics based on Regulation of G-protein Coupled Receptor Targetome연구책임자 : 반현승 / 사업기간 : 2023.01.01 ~ 2023.12.31 |
Research Project |
75 | 2023 | 2023Article FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent mannerCell Death & Disease, vol. 14, no. 8, pp. 567-567Jong Woo Kim; M J Kim; Tae Hee Han; Ji Yoon Lee; Sangok Kim; Hyerin Kim; Kyoung-Jin Oh; Won Kon Kim; Baek Soo Han; Kwang-Hee Bae, et al. |
Article |
74 | 2023 | 2023Article Design, synthesis and biological evaluation of novel MDH inhibitors targeting tumor microenvironmentPharmaceuticals, vol. 16, no. 5, pp. 683-683S Godesi; Jeong-Ran Han; Jang Keun Kim; D I Kwak; J Lee; H Nada; M Kim; Hyun A Yang; Joo-Young Im; Hyun Seung Ban, et al. |
Article |